Leading brokers name 3 ASX shares to buy today

Here's why brokers rate these ASX shares as buys…

With so many shares to choose from on the ASX, it can be hard to decide which ones to buy. The good news is that brokers across the country are doing a lot of the hard work for you.

Three top ASX shares leading brokers have named as buys this week are listed below. Here's why they are bullish on them:

Business man marking buy on board and underlining it.

Image Source: Getty Images

Adairs Ltd (ASX: ADH)

According to a note out of UBS, its analysts have retained their buy rating but cut their price target on this homewares and furniture retailer's shares to $3.25. While the broker acknowledges that the company's outlook could be challenging, it was pleased to see that Adairs is performing in line with its expectations so far in FY 2023. Overall, the broker believes the company's shares offer a lot of value after pulling back materially this year. The Adairs share price is trading at $2.04 on Monday afternoon.

Allkem Ltd (ASX: AKE)

Analysts at Macquarie have retained their outperform rating but trimmed their price target on this lithium miner's shares to $20.00. Although Allkem's quarterly update was mixed and revealed that Olaroz Stage 2 commissioning is behind schedule, the broker remains positive enough to retain its buy rating. This is due to its bullish view on lithium prices and Allkem's growing production. The Allkem share price is fetching $14.79 this afternoon.

Life360 Inc (ASX: 360)

A note out of Bell Potter reveals that its analysts have retained their buy rating and lifted their price target on this location technology company's shares to $9.25. Bell Potter notes that Life360 is increasing prices for all monthly iOS subscribers in the US to the same level which now applies to new monthly iOS and Android subscribers. While this is expected to result in some subscriber churn, trials have been successful and showed lower than expected levels. Bell Potter sees this as a positive and has boosted its estimates and now expects Life360 to be EBITDA profitable in 2023. The Life360 share price is trading at $7.25 on Monday.

Motley Fool contributor James Mickleboro has positions in Allkem Limited and Life360, Inc. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended ADAIRS FPO and Life360, Inc. The Motley Fool Australia has positions in and has recommended ADAIRS FPO. The Motley Fool Australia has recommended Baby Bunting. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A financial expert or broker looks worried as he checks out a graph showing market volatility.
Broker Notes

Buy, hold, sell: Cleanaway Waste Management, New Hope Corporation, CSL shares

Let's check out some new ratings on ASX shares today.

Read more »

Three different hands against a blue backdrop signal thumbs up, indicating share price rise on the ASX market
Broker Notes

3 ASX 200 shares to buy and why: Ord Minnett

The top broker explains its buy recommendations on Fortescue, ARB, and Resmed shares.

Read more »

Piggybank with an army helmet and a drone next to it, symbolising a rising DroneShield share price.
Broker Notes

How high will DroneShield shares go? A broker weighs in

While volatile, the signs are good for this company, Canaccord Genuity says.

Read more »

Woman with her hands out to each side on a light blue background.
Broker Notes

Buy, hold, sell: Ramelius Resources, Medibank, Soul Patts shares

Let's take a look at some new ratings from the experts this week.

Read more »

Two colleagues looking at a graph and comparing share prices.
Broker Notes

Guess which ASX 200 share was just hit with a broker downgrade

Bell Potter has turned lukewarm on this popular stock.

Read more »

Young successful engineer, with blueprints, notepad, and digital tablet, observing the project implementation on construction site and in mine.
Broker Notes

This ASX uranium company is set to surge: Brokers

Despite a project delay this company's shares look cheap, brokers agree.

Read more »

A woman in a red dress holding up a red graph.
Broker Notes

3 ASX shares UBS has tipped to increase 44% to 76%

Three very different companies to choose from.

Read more »

A medical specialist holds a red heart connected via technology and artificial intelligence.
Broker Notes

Morgan Stanley just upgraded their CSL share price target

The blood products company is still looking like a good buy.

Read more »